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Of All Antioxidants, Would One Finally Be Used 
clinically For Atherosclerotic Disease?
Suko Adiarto
Oxidation of LDL by oxygen free radicals results in unregulated uptake of modified LDL by macrophages in arterial wall. This is considered a key initiating factor 
for development and progression of atherosclerotic 
process. It is then logical to hypothesize that anti­
oxidants, which can directly scavenge free radicals, can 
be useful in preventing atherosclerotic process. Initial 
support for this hypothesis accumulated rapidly from 
numerous in­vitro studies.
The evidence was upgraded into the next level 
by studies involving animal models, in which various 
models of atherosclerotic diseases including high 
cholesterol­fed animals and genetically modified 
atherosclerotic mice (apo­E deficient mice) were 
shown to have increased parameters of oxidative 
stress in the arterial walls, including the up­regulation 
of inflammatory cytokines and adhesion molecules 
that preceded the development of atherosclerosis. 
Additionally, administration of antioxidants in these 
animal models resulted in the decrease of not only 
the inflammatory cytokines and adhesion molecules 
but also in the histological evidence of atherosclerosis 
size. 
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The association was further strengthen by 
epidemiological studies in which population with low 
level of antioxidants is associated with a more prevalent 
atherosclerotic disease. In addition, population who 
traditionally consume foods and drinks containing 
antioxidants have significantly lower prevalence of 
atherosclerotic diseases. 
Unfortunately, epidemiological study is as far 
as it can go. Ultimate evidence from interventional 
studies i.e. randomized placebo­controlled clinical 
trials almost uniformly yielded in disappointing results. 
Consequently, antioxidant supplement currently has 
no recommendation in daily practice, although intake 
from their primary food resources especially fruit and 
vegetables should still be encouraged. 
The studies by Hendarto et.al in this edition 
of Indonesian Journal of Cardiology, explored 
the anti­oxidative potentials of xanton, which is 
abundantly contained in mangosteen pericap. They 
showed that supplementation of xanton is dose 
dependently protective against high cholesterol­
induced initiation of atherosclerosis as measured by 
immunohistochemistry of ICAM­1. It is encouraging 
to have the potential anti­oxidative property of 
mangosteen pericap as it is abundantly available in 
the country. However, at least two critical points 
should be seriously considered if this finding is to be 
further investigated for clinical significance. First, it 
is the mangosteen, not the pericap that is consumed 
by human, thus it will be impossible to perform 
diet­based epidemiological study to examine the 
effect of mangosteen pericap on the prevalence of 
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atherosclerotic diseases as have been repeatedly shown 
in Japanese and Chinese population that regularly 
drink green tea. Second, extracting xanton from the 
pericap for interventional study would be similar to 
repeating the failure of previous antioxidants studies 
where extracting one sole active components from the 
natural source is thought to disrupt the interaction 
with other antioxidants and nutrients that resulted 
in the lost of protective effects. 
Only after these two problems can be intelligently 
solved, the potential therapeutic effect of mangosteen 
pericap can be seriously tested in a more clinical and 
causal studies or it may end­up as other antioxidant 
studies that repeatedly fail to find clinical use
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